Gonadorelins adherence in prostate cancer: A time-series analysis of England's national prescriptions during the COVID-19 pandemic (from Jan 2019 to Oct 2020).
Ravina BarrettRobert BarrettKalyan DharBrian R BirchPublished in: BJUI compass (2021)
A worrying decrease in prescription medicines raises concerns for the care of PCa patients. We encourage diagnosed patients to discuss their planned care with their doctor.
Keyphrases
- prostate cancer
- end stage renal disease
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- palliative care
- quality improvement
- peritoneal dialysis
- prognostic factors
- patient reported outcomes
- radical prostatectomy
- adipose tissue
- metabolic syndrome
- insulin resistance
- diabetic retinopathy
- patient reported
- glycemic control